MOUNTAIN VIEW, Calif., Nov. 12, 2013 (GLOBE NEWSWIRE) -- VIVUS,Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing Qsymia® (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today announced the following scientific presentations in connection with Obesity Week 2013:
Pre-Conference
Early Development Pharmacologic and Device Session for Up and Coming Obesity Treatments
Date/Time
Tuesday, November 12, 2013, 12:00 pm - 1:30 pm
Georgia World Congress Center, Room A404-A405
Help employers find you! Check out all the jobs and post your resume.
